---
id: FC-284
type: Flashcard
created: 2025-08-08 10:01:23.201179
tags:
- Flashcard
- question
- cardiovascular
topic: cardiovascular
answer: A
related_articles:
- title: SGLT-2 Inhibitors Reduce Cardiovascular Mortality, but Benefit Is Modest,
    Even in Patients With Established Heart Disease.
  path: 2025/2025-01-sglt-2-inhibitors-reduce-cardiovascular-mortality-but-benefi.md
  similarity: 1.0
  link: '[[2025/2025-01-sglt-2-inhibitors-reduce-cardiovascular-mortality-but-benefi|SGLT-2
    Inhibitors Reduce Cardiovascular Mortality, but Benefit Is Modest, Even in Patients
    With Established Heart Disease.]]'
- title: PREVENT Equations for Assessing Cardiovascular Risk.
  path: 2024/2024-09-prevent-equations-for-assessing-cardiovascular-risk.md
  similarity: 1.0
  link: '[[2024/2024-09-prevent-equations-for-assessing-cardiovascular-risk|PREVENT
    Equations for Assessing Cardiovascular Risk.]]'
- title: 'Management of Heart Failure: Updated Guidelines From the AHA/ACC.'
  path: 2023/2023-09-management-of-heart-failure-updated-guidelines-from-the-aha.md
  similarity: 0.833
  link: '[[2023/2023-09-management-of-heart-failure-updated-guidelines-from-the-aha|Management
    of Heart Failure: Updated Guidelines From the AHA/ACC.]]'
- title: Vericiguat (Verquvo) for the Treatment of Heart Failure.
  path: 2022/2022-11-vericiguat-verquvo-for-the-treatment-of-heart-failure.md
  similarity: 0.833
  link: '[[2022/2022-11-vericiguat-verquvo-for-the-treatment-of-heart-failure|Vericiguat
    (Verquvo) for the Treatment of Heart Failure.]]'
- title: No Benefit With Torsemide Over Furosemide for Posthospitalization Treatment
    of Heart Failure.
  path: 2023/2023-07-no-benefit-with-torsemide-over-furosemide-for-posthospitaliz.md
  similarity: 0.833
  link: '[[2023/2023-07-no-benefit-with-torsemide-over-furosemide-for-posthospitaliz|No
    Benefit With Torsemide Over Furosemide for Posthospitalization Treatment of Heart
    Failure.]]'
topics:
- Blood Pressure
- Cardiology
- Endocrinology
- Psychiatry
related_articles_2023_2025:
- title: editorial cardiovascular disparities south asian people
  path: 2024/07/2024-07-editorial-cardiovascular-disparities-south-asian-people.md
  similarity: 0.308
  link: '[[2024/07/2024-07-editorial-cardiovascular-disparities-south-asian-people|editorial
    cardiovascular disparities south asian people]]'
last_updated: '2025-08-10T20:24:53.938235'
---

# Flashcard FC-284

## Question

A62-year-old patientwhohasheartfailurewithreducedejectionfractionandobesityreportsworsening fatigue. Youadministerthe STOP-BANGquestionnairetoscreenforobstructivesleepapnea(OSA)and findthatthepatienthasahighpretestprobability. Polysomnographyconfirmsthediagnosis. Whichone ofthefollowingisthebestfirst-linetreatmentforthispatient? Positiveairwaypressure(PAP). Amandibularadvancementdevice. Hypoglossalnervestimulation. Uvulopalatopharyngoplasty. @ Back

## Answer

**A**

## Explanation

PAPtherapyimproves OSAseverity,blood pressure,daytimesleepiness,andsleep-relatedqualityoflife. Guidelinesfromthe American Academyof Sleep Medicineandthe U. S. Departmentof Veterans Affairs/U. S. Departmentof Defenserecommendthatallpatientswithsymptomatic OSAbeofferedinitial treatmentwith PAP. Customizable,titratablemandibularadvancementdevicesareanalternative treatmentoptionforpatientswithmildtomoderate OSAwhoarenonadherentto PAPtherapy. Hypoglossalnervestimulationanduvulopalatopharyngoplastymay beconsideredinpatientswhoare intolerantof PAPorasanadjunctto PAP. e

## References

- AAFPQuestion Bank-Pythonsimplecapture.
- whohasheartfailurewithreducedejectionfractionandobesityreportsworsening
- whoarenonadherentto PAPtherapy.
- whoare

